Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cytomx Thera (CTMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,122,340
  • Shares Outstanding, K 38,410
  • Annual Sales, $ 15,040 K
  • Annual Income, $ -58,900 K
  • 36-Month Beta 1.08
  • Price/Sales 21.09
  • Price/Cash Flow N/A
  • Price/Book 23.19

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.15 +16.18%
on 02/09/18
29.26 -0.14%
on 02/23/18
+3.18 (+12.21%)
since 01/23/18
3-Month
19.34 +51.09%
on 12/07/17
29.26 -0.14%
on 02/23/18
+8.52 (+41.16%)
since 11/22/17
52-Week
11.49 +154.31%
on 02/24/17
29.26 -0.14%
on 02/23/18
+17.56 (+150.60%)
since 02/23/17

Most Recent Stories

More News
CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference Call

CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody(TM) therapeutics for the treatment of cancer, plans to report full-year 2017 financial...

CTMX : 29.22 (+2.17%)
Uptrend Call Working As Cytomx Therapeut Stock Rises 67.9% (CTMX)

SmarTrend identified an Uptrend for Cytomx Therapeut (NASDAQ:CTMX) on August 28th, 2017 at $16.05. In approximately 6 months, Cytomx Therapeut has returned 67.91% as of today's recent price of $26.95....

CTMX : 29.22 (+2.17%)
Shares of CTMX Up 57.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Cytomx Therapeut (NASDAQ:CTMX) on August 28th, 2017 at $16.05. In approximately 5 months, Cytomx Therapeut has returned 57.13% as of today's recent price of $25.22....

CTMX : 29.22 (+2.17%)
Cytomx Therapeut Rises 9.31% on Heavy Volume: Watch For Potential Pullback

Cytomx Therapeut (NASDAQ:CTMX) traded in a range yesterday that spanned from a low of $23.20 to a high of $25.21. Yesterday, the shares gained 9.3%, which took the trading range above the 3-day high...

CTMX : 29.22 (+2.17%)
Analysis: Positioning to Benefit within Intellia Therapeutics, United Community Banks, CytomX Therapeutics, First Interstate BancSystem, Global Net Lease, and Enable Midstream Partners -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intellia Therapeutics, Inc....

UCBI : 31.93 (+2.44%)
CTMX : 29.22 (+2.17%)
ENBL : 14.33 (+1.42%)
GNL : 16.40 (+2.18%)
FIBK : 40.40 (+0.62%)
NTLA : 26.12 (+2.15%)
Cytomx Therapeut Up 36.1% Since SmarTrend Uptrend Call (CTMX)

SmarTrend identified an Uptrend for Cytomx Therapeut (NASDAQ:CTMX) on August 28th, 2017 at $16.05. In approximately 4 months, Cytomx Therapeut has returned 36.07% as of today's recent price of $21.84....

CTMX : 29.22 (+2.17%)
CytomX Therapeutics Added to NASDAQ Biotechnology Index

CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody(TM) therapeutics for the treatment of cancer, today announced that the company has...

CTMX : 29.22 (+2.17%)
Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal

While there were not too many updates this week, companies like Regeneron (REGN) and Biogen were in the news related to their pipeline.

CTMX : 29.22 (+2.17%)
REGN : 323.86 (+2.55%)
CPRX : 3.23 (+2.54%)
ALKS : 58.60 (+3.63%)
AMGN : 186.67 (+2.31%)
BIIB : 292.78 (+2.80%)
CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic

Goal is a safer, more effective version of Yervoy

CTMX : 29.22 (+2.17%)
CytomX Announces Third Quarter 2017 Financial Results and Operational Progress

SOUTH SAN FRANCISCO, CA--(Marketwired - Nov 7, 2017) - CytomX Therapeutics, Inc. (NASDAQ: CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer,...

CTMX : 29.22 (+2.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 29.94
1st Resistance Point 29.58
Last Price 29.22
1st Support Level 28.54
2nd Support Level 27.86

See More

52-Week High 29.26
Last Price 29.22
Fibonacci 61.8% 22.47
Fibonacci 50% 20.38
Fibonacci 38.2% 18.28
52-Week Low 11.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.